Patents by Inventor Timothy Joe Miller

Timothy Joe Miller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Stable Immunoprophylactic and Therapeutic Compositions Derived From Transgenic Plant Cells and Methods for Production
    Publication number: 20090087448
    Abstract: The present invention generally relates to the field of immunology and provides immunoprotective compositions and methods for preparing such compositions from transgenic plant cells. The present invention also relates to the field of protein production (e.g., the recombinant production of enzymes, toxins, cell receptors, ligands, signal transducing agents, cytokines, or other proteins expressed in transgenic plant cell culture) and provides compositions comprising these proteins.
    Type: Application
    Filed: October 2, 2008
    Publication date: April 2, 2009
    Applicant: DOW AGROSCIENCES LLC
    Inventors: TIMOTHY JOE MILLER, Matthew James Fanton, Steven Robert Webb
  • Stable immunoprophylactic and therapeutic compositions derived from transgenic plant cells and methods for production
    Publication number: 20040268442
    Abstract: The present invention generally relates to the field of immunology and provides immunoprotective compositions and methods for preparing such compositions from transgenic plant cells. The present invention also relates to the field of protein production (e.g., the recombinant production of enzymes, toxins, cell receptors, ligands, signal transducing agents, cytokines, or other proteins expressed in transgenic plant cell culture) and provides compositions Comprising these proteins.
    Type: Application
    Filed: May 4, 2004
    Publication date: December 30, 2004
    Applicant: Dow AgroSciences LLC
    Inventors: Timothy Joe Miller, Matthew James Fanton, Steven Robert Webb
  • Immunogenic compositions that potentiate growth hormone activity
    Patent number: 6328974
    Abstract: This invention relates to immunogenic compositions capable of potentiality growth hormone activity, comprising an immunologically effective amount of a composite peptide comprising at least two non-contiguous somatotropin epitope amino acid sequences, wherein said composite peptide is substantially free of receptor binding domain sequences; and an immunologically acceptable excipient. The invention further relates to methods of using an immunogenic composition of the invention to potentiate the action of growth hormone in pigs.
    Type: Grant
    Filed: March 26, 1999
    Date of Patent: December 11, 2001
    Assignee: Pfizer Inc
    Inventors: Hector Wasunna Alila, Michael Thomas Clark, Elaine Verne Jones, Timothy Joe Miller, Shawn Patrick O'Brien, Ganesh Madhusudan Sathe
  • Fused somatotropin epitopic peptides that potentiate growth hormone activity
    Patent number: 5889144
    Abstract: This invention relates to composite somatotropin peptides comprising somatotropin epitopic amino acid sequences, and fusion proteins thereof, useful in potentiating growth hormone activity. Also disclosed are vectors and host cells useful in the recombinant production of such molecules. Vaccines containing the composite somatotropin peptides and fusion proteins of the present invention, and methods of using the same, are disclosed.
    Type: Grant
    Filed: April 30, 1997
    Date of Patent: March 30, 1999
    Assignee: Pfizer Inc.
    Inventors: Hector Wasunna Alila, Michael Thomas Clark, Elaine Verne Jones, Timothy Joe Miller, Shawn Patrick O'Brien, Ganesh Madhusudan Sathe
  • Fused proteins
    Patent number: 5686268
    Abstract: This invention relates to composite somatotropin peptides and fusion protein thereof useful in the potentiating of growth hormone activity. Also disclosed are vector and host cells useful in the recombinant production of such molecules. Vaccines containing composite somatotropin and fusion proteins thereof and methods of using same as disclosed.
    Type: Grant
    Filed: January 27, 1995
    Date of Patent: November 11, 1997
    Assignee: Pfizer Inc.
    Inventors: Hector Wasunna Alila, Michael Thomas Clark, Elaine Verne Jones, Timothy Joe Miller, Shawn Patrick O'Brien, Ganesh Madhusudan Sathe